Pfizer Inc (PFE.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 08:51AM CEST
| Previous close | 25.64 |
| Open | 25.69 |
| Bid | 25.86 x 0 |
| Ask | 25.89 x 0 |
| Day's range | 25.69 - 26.09 |
| 52-week range | 23.64 - 34.20 |
| Volume | |
| Avg. volume | 55 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 68% of the company
Key Insights Significantly high institutional ownership implies Pfizer's stock price is sensitive to their trading...
Barrons.comGSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday, while GSK’s American depositary receipt slipped 0.2%. Shares of Moderna a leading mRNA vaccine manufacturer, were up 0.9%.
ZacksPfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
© 2024 Yahoo. All rights reserved.